R ight ventricular (RV) systolic dysfunction is an adverse prognostic marker that has been shown to confer increased risk for heart failure and death. 1-3 RV and left ventricular (LV) performance are closely linked due to a variety of factors, including common coronary arterial blood supply. Patients with LV injury have been shown to develop RV dysfunction in the extreme case of myocardial infarction, for which risk for RV dysfunction varies in relation to LV infarct pattern. 2,4 By extension, LV ischemia holds the potential to impact RV performance, due to both direct (ie, altered RV perfusion) and indirect (ie, increased RV afterload) mechanisms. However, magnitude and distribution of LV ischemia have yet to be studied as markers of RV dysfunction.
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on exercise tolerance is unknown. Given that nearly half of all patients with symptomatic heart failure have preserved LV systolic function, 11 identification of novel parameters that impact effort tolerance-as offered by readily assessable indices of RV function-is of widespread clinical significance.
This study assessed RV function-as well as clinical, exercise, and myocardial perfusion indices-among a broad cohort undergoing echocardiography and exercise MPI so as to test the primary hypothesis that RV dysfunction impairs exercise tolerance independent of LV contractile function. To do so, multimodality imaging was used, whereby MPI was used as the reference for LV perfusion pattern and echo as the reference for RV (and LV) structure/function. Study goals were 3-fold: (1) to assess prevalence and clinical markers of RV dysfunction among patients with known or suspected coronary artery disease (CAD) undergoing exercise stress testing, (2) to determine whether pattern and severity of LV perfusion deficits modifies risk for RV dysfunction, and (3) to test the impact of RV dysfunction on exercise tolerance.
Methods Population
The population comprised consecutive patients who underwent clinically indicated transthoracic echocardiography (echo) within 1 month of exercise single-photon emission computed tomography (SPECT) MPI: A maximum interval of 1 month was selected so as to minimize the impact of changes in loading conditions on RV performance during the interval between tests. Imaging was performed February 2011 to January 2016 at Weill Cornell Medical College. To ensure accurate echo categorization of RV performance, both tricuspid annular plane systolic excursion (TAPSE) and peak tricuspid annular systolic velocity (S′) were required for study inclusion: 7% (n=166) of otherwise eligible patients were excluded due to absence of TAPSE or S′. No patients were excluded based on clinical characteristics or MPI results. This retrospective protocol was approved by the Weill Cornell Medical College Institutional Review Board.
Imaging Protocol

Single-Photon Emission Computed Tomography
MPI was performed in accordance with a previously described protocol using a dual headed scintillation camera system with a low-energy high-resolution collimator. 12, 13 In brief, thallium-201 (≈3 mCi) or technetium-99m sestamibi (≈10 mCi) was injected intravenously; baseline (ie, rest) perfusion images were acquired ≈10 minutes after Tl-201 and 60 minutes after Tc-99m sestamibi injection. Symptom limited exercise treadmill testing was performed using a Bruce protocol: Tc-99m (≈30 mCi) was intravenously administered at peak stress, for which a minimum target heart rate response to exercise (≥85% predicted maximum heart rate [220-age]) was used as the criterion for adequate workload required for radionuclide injection. 14 ECGs and blood pressure measurements were obtained (together with assessment of clinical symptoms) at baseline and at each stage of the exercise treadmill protocol. For patients unable to attain target heart rate during exercise, pharmacological (adenosine or regadenoson) stress was performed after treadmill testing-patients were instructed to refrain from caffeine intake >12 hours before MPI. Either attenuation correction imaging or prone reposition imaging or both, as clinically tolerated, was used to differentiate between pathological perfusion deficits and attenuation artifact in accordance with previously used methods. 12, 15 Poststress images were acquired ≈30 minutes after exercise and 1 to 2 hours after pharmacological stress.
Echocardiography
Noncontrast transthoracic echoes were performed by experienced sonographers using commercially available equipment. Images were acquired in standard parasternal and apical 2-, 3-, and 4-chamber orientations. RV systolic function assessment was performed using M-mode (for TAPSE) and tissue Doppler (for S′) imaging. In accordance with consensus standards, TAPSE and S′ data were acquired in apical 4-chamber orientation. 16 
Image Analysis
Single-Photon Emission Computed Tomography
MPI was interpreted by the American Heart Association/American College of Cardiology level III-trained readers, for whom high reproducibility has been previously reported. 17 Visual interpretation was confirmed by review of polar plots with comparison of segmental radiotracer intensity to computer-generated, sex-matched data sets. Perfusion defect severity on a per-segment basis was graded using a standard 17 segment, 5-point per-segment scoring system (0=normal, 1=equivocal or mildly reduced, 2=moderately reduced, 3=severely reduced, and 4=absence of detectable radioisotope uptake). 18 Fixed segments were defined as those with matched perfusion abnormalities (matched scores) on stress and rest; ischemic segments were defined as those with inducible abnormalities (stress>rest). Summed stress and rest scores were calculated by adding per-segment defect severity for all segments. Inducible perfusion abnormalities (summed difference score) were assessed as the difference between rest and stress images. MPI exams were interpreted blinded to echo-based quantification of RV function.
Regional LV perfusion was assessed using uniform partitions ( Figure 1 ), whereby LV was partitioned into 3 equal size (anterior, inferior, and lateral) territories, in accordance with previous methods as used by our group 15, 19 : summed stress, rest, and difference scores in each territory were calculated as the sum of individual perfusion scores within encompassed segments. Perfusion territories were not mutually exclusive; patients with defects in multiple territories were scored for each territory based on extent and severity of constitutive segmental deficits. Figure 1 . LV perfusion territories. Bullseye plots illustrating regional left ventricular (LV) perfusion territories (highlighted). Each category comprised 5 segments, such that the total myocardium subtended by each was equivalent. RV Dysfunction and Exercise Stress Perfusion Echocardiography Echoes were interpreted by experienced investigators within a highvolume laboratory, for which expertise and reproducibility for quantitative LV and RV indices have been documented. 20, 21 RV systolic function was visually scored and quantified via TAPSE and S′, which were acquired in accordance with consensus guidelines: TAPSE was measured (on M-mode) as the distance of systolic excursion of the lateral tricuspid annulus along its longitudinal plane. S′ was measured (on tissue Doppler) as the peak tricuspid annular longitudinal velocity of excursion. Established cutoffs (TAPSE <1.6 cm, S′< 10 mm/s) were used for each parameter 16 ; cutoffs were defined prospectively for data analysis purposes. To reduce false-positive classification, RV dysfunction was defined by impairment of both TAPSE and S′.
Anterior
Inferior
Additional analyses were performed to assess RV remodeling and ancillary indices relevant to effort tolerance. RV size was measured as the basal linear end-diastolic diameter in a 4-chamber orientation. 22 Pulmonary artery systolic pressure was calculated based on tricuspid regurgitant velocity and inferior vena cava caliber. LV systolic function, geometry, and mass were quantified based on linear dimensions in parasternal long axis, consistent with quantitative methods previously validated in necropsy-comparison and population-based outcomes studies. [23] [24] [25] [26] [27] Mitral regurgitation was graded in accordance with consensus guidelines 28 ; severity was categorized using a 5-point (0-4+) scale based on aggregate data yielded by vena contracta, volumetric indices, jet depth, and mitral and pulmonary vein flow pattern. 15, 29 
Statistical Methods
Comparisons between groups with or without RV dysfunction were made using the Student t test (expressed as mean±SD) for continuous variables. Categorical variables were compared using χ 2 tests or when <5 expected outcomes per cell, the Fisher exact test was used. Multiple group comparisons were performed using 2-way ANOVA; ranked variables (ie, global perfusion scores) were compared using the Kruskal-Wallis test. Multivariable logistic regression analysis was used to test whether LV perfusion deficit pattern was independently associated with RV dysfunction after controlling for magnitude of LV systolic dysfunction and RV afterload (ie, pulmonary artery pressure); variables were concomitantly entered into the multivariable model after each were confirmed to be associated with RV dysfunction in univariable analysis. Linear regression was used to test variables associated with exercise time. Statistical calculations were performed using SPSS 22.0 (SPSS, Inc, Chicago, IL). Two-sided P<0.05 was considered indicative of statistical significance.
Results
Population Characteristics
The study population comprised 2051 patients who underwent echo and MPI within 1 month (mean: 5.5±7.9 days [73% within 7 days]) reflecting 15.9% (2051/12 841) of all patients who underwent MPI during study period. Among the study population, 6.0% (n=123) had echo-evidenced RV dysfunction as manifested by both impaired TAPSE and RV S′. Table 1 details population characteristics stratified by RV functional status, including clinical conditions and patientreported baseline medications at the time of MPI. As shown, diabetes mellitus and hypertension were more common among patients with RV dysfunction (P<0.05), paralleling increased prevalence of clinically reported obstructive CAD at time of stress testing (P<0.001). Consistent with the concept that adverse LV remodeling impacts RV performance, both MPI and echo demonstrated that LV systolic function was lower, LV chamber size larger, and pulmonary artery pressure higher among patients with RV dysfunction (all P<0.01). Of note, Table 1 also demonstrates that less than half (40%) of patients with quantitative RV dysfunction as measured via TAPSE and S′ were identified based on qualitative visual assessment alone. Table 2 compares perfusion indices in relation to RV function, including its composite parameters of TAPSE and S′. As shown, global LV summed stress scores were on average ≈3-fold higher among patients with RV dysfunction, attributable to increments in inducible (summed difference score) and fixed perfusion defects (all P≤0.001). Perfusion defect severity was paralleled by increased defect size, as measured based on greater number of segments with inducible and fixed perfusion defects among patients with RV dysfunction (both P<0.001). Regarding regionality, both inferior and lateral wall ischemia was greater among patients with RV dysfunction (both P≤0.01), whereas corresponding anterior wall defects (whether measured based on summed difference score or number of ischemic segments) were similar (P≥0.13). Table 2 also demonstrates that perfusion defect findings associated with the composite definition of RV dysfunction by both TAPSE and S′ were similar with RV dysfunction defined by each of the 2 individual parameters. Multivariable logistic regression analysis ( Table 3 ) was used to test whether LV perfusion deficit pattern was independently associated with RV dysfunction after controlling for conventional factors.
Myocardial Perfusion Pattern
As shown in Table 3 , inducible myocardial perfusion defects (as measured in the inferior or lateral walls) increased the likelihood of RV dysfunction (both P<0.05). Of note, modeling data demonstrated that the relationship between RV dysfunction and LV perfusion deficits was continuous, such that likelihood of RV dysfunction increased in relation to size of LV perfusion deficit. Applied clinically, results indicate that ischemic perfusion deficits involving 3 LV segments in the inferior or lateral walls would be expected to more than double the likelihood for RV dysfunction even after controlling for magnitude of LV dysfunction and pulmonary hypertension.
RV Function in Relation to Effort Tolerance
All patients initiated a standardized Bruce exercise treadmill protocol, for which a target of 85% predicted maximal heart rate (220-age) was required for test completion. As shown in Table 4 , exercise-induced hemodynamic indices, including change in heart rate and systolic blood pressure, were lower among patients with RV dysfunction (both P<0.001): results paralleled differences among patients with LV systolic dysfunction defined by ejection fraction <50% (Δheart rate: 60±27 versus 70±24 bpm|Δblood pressure: 33±31 versus 42±27 mm Hg; both P≤0.001). Patients with RV dysfunction also demonstrated lesser effort tolerance whether measured by exercise duration or peak Bruce stage achieved (both P<0.001), again paralleling results among patients with LV dysfunction (7.0±2.9 versus 8.0±2.9|2.7±1.0 versus 3.1±1.0; both P<0.001). Accordingly, both groups were more likely to require conversion of exercise testing to pharmacological stress (RV dysfunction: 35% versus 19%; P<0.001|LV dysfunction: 27% versus 19%; P=0.03). Figure 2 stratifies exercise time in relation to RV and LV systolic function. As shown, effort tolerance decreased in relation to both functional parameters, as evidenced by stepwise 
Discussion
This study-performed among a broad cohort of patients undergoing stress MPI and echo-provides new insights concerning links between LV ischemia and RV performance, as well as the independent impact of RV dysfunction on effort tolerance. There are several key findings: first, although RV dysfunction was uncommon (6%) among the overall cohort of patients undergoing MPI, prevalence was higher among patients with CAD risk factors and markedly increased (63%) among those with known CAD (P<0.001). Second, regional LV perfusion impacted likelihood of RV dysfunction, as evidenced by the fact that both inferior and lateral wall ischemia was greater among patients with RV dysfunction (both P≤0.01), whereas corresponding anterior wall deficits (whether measured based on summed difference score or number of ischemic segments) were similar. In multivariable analysis, inducible perfusion defects in the LV inferior or lateral walls were independently associated with RV dysfunction even after controlling for magnitude of LV dysfunction, fixed defects, and pulmonary artery systolic pressure. Finally, multiple physiological indices of effort tolerance (eg, Δheart rate, Δblood pressure, effort time) were impaired among patients with RV dysfunction (all P<0.001), paralleling results among patients with LV dysfunction: exercise time decreased stepwise in relation to both RV and LV dysfunction (P<0.001) and was associated with each parameter independent of age or medication regimen.
To the best of our knowledge, this is the first study to demonstrate a link between LV ischemia and RV function. Our observed association between inferior and lateral wall inducible perfusion defects and RV dysfunction is consistent with established concepts regarding LV perfusion pattern and RV blood flow. Previous studies have shown inferior and lateral wall perfusion deficits on MPI to correspond to occlusion of the right coronary and left circumflex arteries, 30 each of which would be expected to variably provide blood flow to the RV based on coronary dominance pattern. Of note, anterior ischemia was not associated with RV dysfunction despite the fact that the left anterior descending artery often provides blood flow to the RV apex. One possible explanation for this concerns the measurement technique used to 16 both are measures of tricuspid annular/basal RV excursion and would not necessarily be impacted by regional dysfunction of the RV apex. Concerning our observation that anterior fixed defects were larger among patients with RV dysfunction, it is possible that the distal RV (as may be supplied by the left anterior descending artery) contributes relatively little to global RV performance, such that anterior ischemia itself bears minimal consequences for RV function, but that anterior infarction produces adverse LV remodeling that bears secondary consequences on RV performance. Consistent with this, several previous studies have shown RV dysfunction (measured via echocardiography, radionuclide cine-angiography, or cardiac magnetic resonance) to be less common among patients with anterior MI 2,4 but present in 17% to 40% of such cases. 2, 4, 31 Taken together, these data suggest that our findings are consistent with previous Our observed link between RV dysfunction and reduced exercise supports the notion that RV dysfunction alone can impede effort tolerance-a physiological parameter widely used to stratify prognosis that has been shown to predict cardiovascular and overall mortality in previous studies. [7] [8] [9] [10] Among our cohort, effort tolerance was >1 minute lower among patients with isolated RV dysfunction compared with those with normal biventricular function, paralleling similar magnitude of difference when patients with isolated LV dysfunction were compared with normal controls (both P≤0.001). Our data among patients with known or suspected CAD extends on previous studies in smaller cohorts, which have suggested an association between RV dysfunction and exercise capacity but have not directly tested whether RV dysfunction provides incremental stratification above that yielded by LV function alone. For example, among a cohort of 23 healthy adolescents undergoing cardiopulmonary exercise testing, Pieles et al 32 reported that both RV and LV strain increased in relation to work rate (P<0.05). Moreover, among 44 chronic obstructive pulmonary disease patients, Caminiti et al 33 reported that those with RV dysfunction (as defined via TAPSE) had lower effort tolerance on baseline 6-minute walk test (P=0.02) and lesser improvement after cardiopulmonary rehabilitation (P<0.001). Other studies conducted among patients with LV systolic dysfunction have linked reduced right ventricular ejection fraction to impaired exercise capacity as measured via peak oxygen consumption (V0 2 max) during bicycle ergometry or treadmill exercise. 34-36 About mechanism, it is possible that impaired RV function results in decreased LV preload, thereby altering LV pressure-volume filling curves and impeding LV contractile mechanics. It is also possible that abnormal RV function (as measured by TAPSE or S′) is a marker for subtle changes in LV systolic function not captured by widely used indices such as left ventricular ejection fraction, such that LV contractile function is the primary determinant of effort tolerance and RV dysfunction a secondary marker. Regardless of mechanism, our data indicate RV dysfunction confers increased likelihood for impaired exercise capacity, adding to a growing body of literature demonstrating the importance of RV function as a marker of effort tolerance. [1] [2] [3] [34] [35] [36] Several limitations should be noted. First, it is important to recognize that SPECT does not assess absolute quantitative blood flow and that this modality does not provide sufficient spatial resolution to assess RV perfusion. On the contrary, SPECT is widely used to assess ischemic burden, enabling us to study a broad population-based cohort using a perfusion approach that is well validated for prognostic risk stratification. 5 Second, our study assessed RV performance based on TAPSE and S′ and used established binary cutoffs rather than examining magnitude of dysfunction based on volumetric right ventricular ejection fraction. Although TAPSE and S′ are included in consensus guidelines 16 and can be readily applied in clinical practice and research, these methods extrapolate global function based on tricuspid annular regional excursions, potentially excluding the effect of RV apical dysfunction. Therefore, volumetric assessment using 3-dimensional echo or cardiac magnetic resonance may have yielded differing results given its superior ability to detect RV dysfunction as compared to 2-dimensional imaging alone. 3, 37 On the contrary, TAPSE and S′ have been shown to correlate with volumetric RV function 20 and offer a means of RV assessment for patients in whom 3-dimensional methods (eg, cardiac magnetic resonance) are contraindicated or unavailable, providing a rationale for our imaging approach. An additional limitation concerns the fact that chest pain history was assessed via patient questionnaire at time of exercise MPI (for which available data were insufficient to classify chest pain features) and that exercise treadmill data did not include postexercise variables such as heart rate recovery. It is also important to note that SPECT assessment of ischemia burden was performed via standardized scoring of perfusion defect severity and did not include ancillary indices such as lung-heart ratio. Finally, due to large number of statistical tests used, type I error maybe inflated using the prespecified P value cutoff (<0.05) as the significance threshold per test.
Our results bear several key implications for clinical practice and translational research. First, our finding of an independent association between RV dysfunction and decreased exercise treadmill time supports the notion that RV performance should be evaluated as part of diagnostic testing among patients with impaired effort capacity or associated symptoms. Second, our results add to growing literature supporting use of quantitative RV assessment for stratification of physiological outcomes and demonstrate that simple RV visual assessment (an approach widely used in current clinical practice) can be limited-as evidenced by the fact that less than half (40%) of patients in our cohort with quantitative RV dysfunction were identified qualitatively. Finally, given our demonstration of links between LV inferior/lateral Exercise time (during Bruce treadmill protocol) among groups partitioned based on left ventricular (LV) and right ventricular (RV) systolic function (LV dysfunction P=0.034; RV dysfunction P=0.008; interaction P=0.38). As shown, exercise time decreased in relation to extent of systolic dysfunction, as evidenced by stepwise decrements between patients with normal biventricular function, isolated LV or RV dysfunction, and those with biventricular dysfunction. LVEF indicates left ventricular ejection fraction; and TAPSE, tricuspid annular plane systolic excursion. RV Dysfunction and Exercise Stress Perfusion ischemia and RV dysfunction, future multicenter studies are warranted to further confirm our findings and test whether targeted coronary revascularization in these regions can be used as a therapeutic means of augmenting RV contractility and clinical performance status among patients with CAD.
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